Global Pharmaceutical Stability Testing Market Trends, Opportunities, and Future

Consolidated Stability Storage is Leading to CROs Evolving into Development Partners and Driving the Stability Testing Outsourcing Market

USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

This research service on the global pharmaceutical stability testing market addresses market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year is 2015 and forecasts are provided from 2016 to 2020.

The market is expected to grow at a CAGR of 9.4% till 2020, driven by an explosion of new approval applications, consolidation, and globalization of both small and large molecule industries. Also, with the continuous growth of biologics, the global pharmaceutical stability testing market is expected to witness robust growth. Biologics stability testing, being more complicated than that of small molecules, is expected to contribute significantly to overall revenue. Biopharmaceutical companies are consolidating stability storage and limiting testing to one facility whereas pharmaceutical companies are moving toward decentralized stability testing, and centralized management and reporting. These companies are opting for single stability storage deals and building strategic relationships with CROs. Also, they are looking for end-to-end services to outsource the entire development project to a single CRO.

Early-stage biotech is identified as the largest growth segment for stability services, and has posted the highest increase during the past few years. For new-generation therapies and new trends in formulations such as non-aqueous and liposomal, many original study strategies apply but new strategies need to be adopted to deal with some of the nuances. Asia-Pacific, especially India and China, is emerging as a big growth opportunity area for this market. Several large CROs are exploring acquisitions here. Many local participants in these markets provide specialized services for global participants. There is also high demand for stability testing for such products in the local markets.

Table of Contents

Global Pharmaceutical Stability Testing Market Trends, Opportunities, and FutureExecutive SummaryKey FindingsScope and SegmentationScope and SegmentationStability Testing in Biologics and Pharmaceutical Development CycleStability Testing PhasesTrends in Global Pharmaceutical Stability Testing MarketMarket OverviewGlobal Market PerspectiveFactors Affecting Drug Product StabilityICH-Recommended Stability Study ConditionsICH Climate Stability ZonesMarket Revenue ForecastRevenue ForecastRevenue Forecast DiscussionTrends in Pharmaceutical Stability Testing OutsourcingBenefits of Outsourcing Stability Testing ServicesIn-house and Outsourcing Stability StudiesTrends in Pharmaceutical Stability Testing—Small and Large MoleculesSmall and Large Molecules Stability Testing SegmentSmall and Large Molecules Stability Testing Segment SizeRegional Trends in Stability TestingRegional Trends in Pharmaceutical Stability TestingKey Technology Trends New TherapiesNew Therapy ChallengesNew Therapy Challenges (continued)New Therapy Challenges (continued)New Therapy Challenges (continued)Trends in FormulationsAnalysis of Customer BaseCustomer Base Analysis for Stability TestingCollaborations between CROs and CustomersVoice of Customer—Key Requirements Before and After Outsourcing Stability StudiesVoice of Customer—Requirements from Contract Service Providers or Unmet Market NeedsGrowth OpportunitiesGrowth Opportunities for the Pharmaceutical Stability Testing MarketCompany ProfilesCharles River LaboratoriesEurofins ScientificIntertekBioRelianceGeographical Breakdown of Other Major Competitors*North AmericaNorth America (continued)North America (continued)EuropeAsia-PacificThe Last WordKey TakeawaysLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 07-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 17-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.